Treatment of Refractory Hand and Foot Eczema with Nail Involvement Using Upadacitinib: A Case Report

Abstract

Get full access to this article

View all access options for this article.

References

Voorberg

, Niehues

, Oosterhaven

JAF

, et al. Vesicular hand eczema transcriptome analysis provides insights into its pathophysiology. Exp Dermatol, 2021; 30(12):1775–1786. doi: 10.1111/exd.14428

Navarro-Triviño

, Galán-Gutiérrez

, Hita

, et al. Real-world clinical experience of dupilumab in the treatment of chronic palmo-plantar eczema in patients with moderate-severe atopic dermatitis: 52-week follow-up. Dermatitis, 2024; 35(S1):S55–S61. doi: 10.1089/derm.2023.0220

Sitaru

, Preis

, Eberlein

. Successful treatment of atopic hand and foot eczema with oral janus kinase 1 inhibition. Dermatitis, 2023; 34(6):560. doi: 10.1089/derm.2022.0030

Lee

, Ahn

, Shin

. Nine cases of chronic hand and foot eczema treated with baricitinib. Australas J Dermatol, 2023; 64(3):408–412. doi: 10.1111/ajd.14074

Simpson

, Rahawi

, Hu

, et al. Effect of upadacitinib on atopic hand eczema in patients with moderate-to-severe atopic dermatitis: Results from two randomized phase 3 trials. J Eur Acad Dermatol Venereol, 2023; 37(9):1863–1870. doi: 10.1111/jdv.19194